Andere Kunden interessierten sich auch für
![Prävalenz, Risikofaktoren von Prädiabetes in der Region Andijan]( "Prävalenz, Risikofaktoren von Prädiabetes in der Region Andijan")
Prävalenz, Risikofaktoren von Prädiabetes in der Region Andijan60,90 €![Prevalence, Associated Risk Factors for intestinal Parasites in Amuria]( "Prevalence, Associated Risk Factors for intestinal Parasites in Amuria")
Prevalence, Associated Risk Factors for intestinal Parasites in Amuria27,99 €![FINDRISC instrument, risk of prediabetes and type 2 diabetes mellitus.]( "FINDRISC instrument, risk of prediabetes and type 2 diabetes mellitus.")
FINDRISC instrument, risk of prediabetes and type 2 diabetes mellitus.29,99 €![Prevalence, Profile and Outcomes of High Blood Pressure]( "Prevalence, Profile and Outcomes of High Blood Pressure")
Prevalence, Profile and Outcomes of High Blood Pressure36,99 €![Crossing over in the HLA region]( "Crossing over in the HLA region")
Crossing over in the HLA region29,99 €![Child pneumonia in the Western Pacific region]( "Child pneumonia in the Western Pacific region")
Child pneumonia in the Western Pacific region46,99 €![Pulmonary Embolism. Prevalence, Diagnosis and Management]( "Pulmonary Embolism. Prevalence, Diagnosis and Management")
Pulmonary Embolism. Prevalence, Diagnosis and Management15,95 €
In the 21st century, diabetes mellitus (types 1 and 2) and prediabetic conditions-impaired glucose tolerance and impaired fasting glucose-remain among the most pressing problems of modern medicine, leading to early cardiovascular complications. Worldwide, the number of people with diabetes and prediabetes continues to grow, especially amid worsening epidemiological conditions and the spread of major cardiovascular risk factors. According to the Uzbek National Diabetes Registry (2007, 2010) and official data, about 80% of patients fail to achieve target carbohydrate metabolism indicators, contributing to diabetic and cardiovascular complications. Diabetes and prediabetes are rapidly increasing and, as the WHO warns, represent not only a medical but also a social issue. By 2045, the number of diabetics may reach 629 million, making it the 7th leading cause of death. The monograph presents the results of research aimed at finding cost-effective strategies for early diagnosis, prevention, and treatment of diabetes. It is intended for family doctors, endocrinologists, cardiologists, medical students, and educators.